Managing patient adherence and quality of life in epilepsy

Por Eatock, Joanne, Baker, Gus A
Publicado em 2007

Self-reported feelings of anger and aggression towards others in patients on levetiracetam: data from the UK antiepileptic drug register

Por Wieshmann, Udo Carl, Baker, Gus A
Publicado em 2013

Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero

Por Bromley, Rebecca L., Baker, Gus A., Meador, Kimford J.
Publicado em 2009

Semantic memory is impaired in patients with unilateral anterior temporal lobe resection for temporal lobe epilepsy

Por Lambon Ralph, Matthew A., Ehsan, Sheeba, Baker, Gus A., Rogers, Timothy T.
Publicado em 2012

Multiple impacts of epilepsy and contributing factors: findings from an ethnographic study in Vietnam

Por Aydemir, Nuran, Vu Trung, Dang, Snape, Dee, Baker, Gus A, Jacoby, Ann
Publicado em 2009

The stigma of people with epilepsy is demonstrated at the internalized, interpersonal and institutional level in a specific socio-cultural context: findings from an ethnographic st...

Por Guo, Wencui, Wu, Jianzhong, Wang, Wenzhi, Guan, Biyan, Snape, Dee, Baker, Gus A, Jacoby, Ann
Publicado em 2012

Stigma of People with Epilepsy in China: Views of health professionals, teachers, employers and community leaders

Por Yang, Rongrong, Wang, Wenzhi, Snape, Dee, Chen, Gong, Zhang, Lei, Wu, Jianzhong, Baker, Gus A, Zheng, Xiaoying, Jacoby, Ann
Publicado em 2011

NRSF and BDNF polymorphisms as biomarkers of cognitive dysfunction in adults with newly diagnosed epilepsy

Por Warburton, Alix, Miyajima, Fabio, Shazadi, Kanvel, Crossley, Joanne, Johnson, Michael R., Marson, Anthony G., Baker, Gus A., Quinn, John P., Sills, Graeme J.
Publicado no Epilepsy Behav (2016)

Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery

Por Powell, Graham, Holmes, Emily A F, Plumpton, Catrin O, Ring, Adele, Baker, Gus A, Jacoby, Ann, Pirmohamed, Munir, Marson, Anthony G, Hughes, Dyfrig A
Publicado no Br J Clin Pharmacol (2015)

The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs

Por Bromley, Rebecca L, Mawer, George E, Briggs, Maria, Cheyne, Christopher, Clayton-Smith, Jill, García-Fiñana, Marta, Kneen, Rachel, Lucas, Sam B, Shallcross, Rebekah, Baker, Gus A
Publicado em 2013

Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age

Por Meador, Kimford J., Baker, Gus A., Browning, Nancy, Cohen, Morris J., Clayton-Smith, Jill, Kalayjian, Laura A., Kanner, Andres, Liporace, Joyce D., Pennell, Page B., Privitera, Michael, Loring, David W.
Publicado em 2011

Relationship of Child IQ to Parental IQ and Education in Children with Fetal Antiepileptic Drug Exposure

Por Meador, Kimford J., Baker, Gus A., Browning, Nancy, Clayton-Smith, Jill, Cohen, Morris J., Kalayjian, Laura A., Kanner, Andres, Liporace, Joyce D., Pennell, Page B., Privitera, Michael, Loring, David W.
Publicado em 2011

Fetal Antiepileptic Drug Exposure: Motor, Adaptive and Emotional/Behavioral Functioning at Age 3 Years

Por Cohen, Morris J., Meador, Kimford J., Browning, Nancy, Baker, Gus A., Clayton-Smith, Jill, Kalayjian, Laura A., Kanner, Andres, Liporace, Joyce D., Pennell, Page B., Privitera, Michael, Loring, David W.
Publicado em 2011

Antiepileptic drug use in women of childbearing age

Por Meador, Kimford J., Penovich, Patricia, Baker, Gus A., Pennell, Page B., Bromfield, Edward, Pack, Alison, Liporace, Joyce D., Sam, Maria, Kalayjian, Laura A., Thurman, David J., Moore, Eugene, Loring, David W.
Publicado em 2009

Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs

Por Meador, Kimford J., Baker, Gus A., Browning, Nancy, Clayton-Smith, Jill, Combs-Cantrell, Deborah T., Cohen, Morris, Kalayjian, Laura A., Kanner, Andres, Liporace, Joyce D., Pennell, Page B., Privitera, Michael, Loring, David W.
Publicado em 2009

Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6 years

Por Cohen, Morris J., Meador, Kimford J., Browning, Nancy, May, Ryan, Baker, Gus A., Clayton-Smith, Jill, Kalayjian, Laura A., Kanner, Andres, Liporace, Joyce D., Pennell, Page B., Privitera, Michael, Loring, David W.
Publicado em 2013

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study

Por Meador, Kimford J, Baker, Gus A, Browning, Nancy, Cohen, Morris J, Bromley, Rebecca L, Clayton-Smith, Jill, Kalayjian, Laura A, Kanner, Andres, Liporace, Joyce D, Pennell, Page B, Privitera, Michael, Loring, David W
Publicado em 2013

Breastfeeding in Children of Women Taking Antiepileptic Drugs: Cognitive Outcomes at Age 6 Years

Por Meador, Kimford J., Baker, Gus A., Browning, Nancy, Cohen, Morris J., Bromley, Rebecca L., Clayton-Smith, Jill, Kalayjian, Laura A., Kanner, Andres, Liporace, Joyce D., Pennell, Page B., Privitera, Michael, Loring, David W.
Publicado em 2014

IQ at 6 years after in utero exposure to antiepileptic drugs: A controlled cohort study

Por Baker, Gus A., Bromley, Rebecca L., Briggs, Maria, Cheyne, Christopher P., Cohen, Morris J., García-Fiñana, Marta, Gummery, Alison, Kneen, Rachel, Loring, David W., Mawer, George, Meador, Kimford J., Shallcross, Rebekah, Clayton-Smith, Jill
Publicado no Neurology (2015)

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

Por Marson, Anthony G, Al-Kharusi, Asya M, Alwaidh, Muna, Appleton, Richard, Baker, Gus A, Chadwick, David W, Cramp, Celia, Cockerell, Oliver C, Cooper, Paul N, Doughty, Julie, Eaton, Barbara, Gamble, Carrol, Goulding, Peter J, Howell, Stephen J L, Hughes, Adrian, Jackson, Margaret, Jacoby, Ann, Kellett, Mark, Lawson, Geoffrey R, Leach, John Paul, Nicolaides, Paola, Roberts, Richard, Shackley, Phil, Shen, Jing, Smith, David F, Smith, Philip E M, Smith, Catrin Tudur, Vanoli, Alessandra, Williamson, Paula R
Publicado em 2007